Biofil Chemicals & Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023, to consider and approve un-audited Financial Results for the quarter as well as half year ended on 30th September, 2023 along with limited review report thereon and any other matter with the permission of chair. The Company is submitting the above said information in XBRL mode along with the submission in PDF mode.
The above information is a part of company’s filings submitted to BSE.